Clinical Trial Results:
A Randomized, Double-Blind Study Comparing the Safety and Efficacy of Once-Weekly
Administration of Etanercept 50 mg, Etanercept 25 mg, and Placebo in Combination With Methotrexate in Subjects With Moderately Active Rheumatoid Arthritis Who Have Achieved an Adequate Response With Etanercept 50 mg Once Weekly and ethotrexate
Summary
|
|
EudraCT number |
2007-000896-41 |
Trial protocol |
HU NL ES SE BE FR CZ DE AT IT GB |
Global completion date |
30 May 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
08 Mar 2016
|
First version publication date |
13 Feb 2015
|
Other versions |
|
Summary report(s) |
0881A1-4423 results |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.